医学
阿替唑单抗
贝伐单抗
肝细胞癌
肿瘤科
内科学
癌
化疗
癌症
免疫疗法
无容量
作者
Richard S. Finn,Shukui Qin,Masafumi Ikeda,Peter R. Galle,Michel Ducreux,Tae‐You Kim,Masatoshi Kudo,В. В. Бредер,Philippe Merle,Ahmed O. Kaseb,Daneng Li,Wendy Verret,Derek-Zhen Xu,Sairy Hernandez,Juan Liu,Chen Huang,Sohail Mulla,Yulei Wang,Ho Yeong Lim,Andrew X. Zhu
标识
DOI：10.1056/nejmoa1915745
摘要
The combination of atezolizumab and bevacizumab showed encouraging antitumor activity and safety in a phase 1b trial involving patients with unresectable hepatocellular carcinoma.
科研通智能强力驱动
Strongly Powered by AbleSci AI
cdercder
科研小民工
昏睡的蟠桃
iNk
迷人秋烟
子车茗
斯寜
剑指东方是为谁
彭于彦祖
劲秉
SYLH
andong
HEIKU
FIN
kingwill
back you up
fjh
YifanWang
nozero
椰子在长江送礼物
皖公网安备34019202002308
